Coave Therapeutics has announced its lead gene therapy program, CoTx-101, for the treatment of retinal vascular diseases, ...

After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation ...

After revoking Sarepta’s designation in July and awarding one to Krystal last month, the FDA’s platform technology ...

Authors, Creators & Presenters: Miaomiao Wang (Shanghai University), Guang Hua (Singapore Institute of Technology), Sheng Li (Fudan University), Guorui Feng (Shanghai University) ----------- PAPER A ...

tebu-bio offers recombinant protein production services using a robust, inexpensive and fast transient-expression system in Chinese hamster ovary (CHO) cells, for various research and development ...

The latest update is out from Targovax ASA ( (GB:0RIS) ).

The SRV8 was hastily built from the bones of the final pre-production M12. Engine displacement is still 5.7 liters, but here ...

At PEGS Europe 2025, one of the industry's premier gatherings for innovation in protein and antibody engineering, Tsingke Biotech highlighted its latest accelerated protein and antibody services. The ...

Good morning, and welcome to the Jefferies 2025 Healthcare Conference. It's my pleasure now to introduce David Kirn, CEO; and Chris Simms, Chief Commercial Officer of 4D Molecular Therapeutics. All ...

Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for ...

A new research paper was published in Volume 16 of Genes & Cancer on October 31, 2025, titled “P3a site-specific and cassette mutagenesis for seamless protein, RNA and plasmid engineering.” ...

Four key concepts are essential for understanding Clojure’s functional programming paradigm. Here’s how to apply what you ...